HiWith reference to your last sentence:I am also taking above my...

First 282 Last

Share
Profile

Follow
Pupafly

208 Posts.

41

09/12/23

12:41

Post #: 71361675
Share

Originally posted by dolcevita: ↑

The path to gaining FDA approval has been more difficult than for most and while it's natural to feel worn down, it's very important to be mindful of what makes the situation unique:
- novel stem cell based therapy so FDA had no precedent for it (this is crucial to appreciate... downrampers love to pretend the FDA had a clear pathway to approval but they did not)
- FDA chopping and changing their requirements (due to inexperience, incompetence and probably sheer bloodymindedness take your pick, especially when ignoring the advice of their own expert committees but getting suddenly finicky over batch assays when there is no issue with effectiveness of the actual therapy, so just fine tuning causing yet another delay)
- Covid19 throwing a spanner in the works of clinical trials (no need to go into this, patient trials were derailed even those involving ARDS because of a lack of patients who were not compromised by other drugs)
- Licensing Deal of the Year win/win partnership with Cephalon getting blown up by Teva takeover (Teva then succeeding in blowing itself up)
- opportunistic potential partners getting cold feet instead of staying the course probably because of the ridiculous obstacles above
- at key times such as this and the Nasdaq listing there have been short ladder attacks, misleading analyst reports (lest we forget Macquarie Investments, and Regal suddenly emerging as a major holder, when the analyst from Macquarie who had downramped MSB, suddenly turned up at Regal) so bad the company was forced to issue a corrective Ann, it goes on and on and ON

But sympathetic as I am with your long holdings and I am a LT holder too, it is IMO a mistake to shoot ALL of the blame onto SI and management when contending with the sheer magnitude of all of this.

It is epic.

If there were any missteps by our team, they pale into insignificance.

This is what I mean by keeping a sense of proportion. Especially when we are so close to getting this over the line as we have seen in the updates at the AGM. We only need one approval and it all starts to fall into place.

Please take a look at the accounts posted about people who held on and made serious money with game changing technologies. Think about how long CSL was under wraps within government before being listed and the game changing. There are very useful parallels there.

I am taking above my offer amount and backing this company because it's the ethical thing to do and it makes sense to do so. IMO.

Expand

Hi

With reference to your last sentence:

I am also taking above my offer amount but at 28.5c you will agree it makes sense to do so.

MSB Price at posting: 28.5¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

TLX

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

TX3

Canadian fieldwork yields multiple pegmatites for Trinex

RNU

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

AUG

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

There are more pages in this discussion • 260 more messages in this thread...

First 282 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last $1.11		Change 0.010(0.91%)		Mkt cap ! $1.261B

Open	High	Low	Value	Volume
$1.09	$1.11	$1.07	$4.794M	4.399M

Buyers (Bids)

No.	Vol.	Price($)
2	14500	$1.10

Sellers (Offers)

Price($)	Vol.	No.
$1.11	141676	5

View Market Depth

No.	Vol.	Price($)
2	14500	1.100
2	93112	1.095
2	37684	1.090
3	40400	1.085
2	61100	1.080

Price($)	Vol.	No.
1.110	141676	5
1.115	41050	3
1.120	157964	9
1.125	61233	3
1.130	111595	5

Last trade - 16.10pm 11/07/2024 (20 minute delay)

MSB (ASX) Chart

HiWith reference to your last sentence:I am also taking above my...

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

Canadian fieldwork yields multiple pegmatites for Trinex

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

HiWith reference to your last sentence:I am also taking above my...

Top Stories

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

Canadian fieldwork yields multiple pegmatites for Trinex

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News